The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.
- Past awards
- 7
- 7 new
- Median first-year cost
- $1,038,176
- $7,466,093 in all
- Institutions
- 7
- 7 contact PIs
- Patents
- 5
- from 1 funded project
Awards by fiscal year
Fiscal years 2014 to 2026.
Most frequent institutions
- ALBERT EINSTEIN COLLEGE OF MEDICINE1
- BAYLOR COLLEGE OF MEDICINE1
- CASE WESTERN RESERVE UNIVERSITY1
- INDIANA UNIVERSITY INDIANAPOLIS1
- JOHNS HOPKINS UNIVERSITY1
and 2 other institutions
Most frequent study sections
- Special Emphasis Panel (ZCA1 TCRB-D (M1))7
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| FY2020 | Pediatric HIV/AIDS & Infection-Related Malignancies Research Consortium for sub-Saharan Africa (PARCA)1U54CA254569-01 | Allen, Carl EJoloba, Moses LutaakomeScheurer, Michael E. | BAYLOR COLLEGE OF MEDICINE, TX | First-year cost $1,185,076 | Study section ZCA1 |
| FY2020 | Innovations for screening and prognosis in HIV+ cancers including Kaposi sarcoma, cervical cancer, and lymphoma in Malawi and South Africa1U54CA254564-01 | Chibwesha, Carla JDamania, Blossom ADittmer, Dirk PFedoriw, YuriRuff, PaulTweya, Hannock Mukoma | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | First-year cost $1,180,460 | Study section ZCA1 |
| FY2020 | United States-East Africa HIV-Associated Malignancy Research Center (USEAHAMRC) for Career Development and the Prevention, Early Detection and Efficient Linkage to Care for Virus-related Cancers1U54CA254571-01 | Kambugu, Andrew DdunguMartin, Jeffrey N | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | First-year cost $1,054,123 | Study section ZCA1 |
| FY2020 | HIV and HCC in Africa: The H2A Consortium1U54CA254565-01 | Kirk, Gregory DOcama, Ponsiano | JOHNS HOPKINS UNIVERSITY, MD | First-year cost $1,038,176 | Study section ZCA1 |
| FY2020 | Lung cancer in East Africa and the relationship to HIV-1 infection: epidemiology, molecular characterization and imaging1U54CA254566-01 | Gerson, Stanton L.Kirenga, Bruce JamesMfinanga, Godfrey SayokiSalata, Robert A | CASE WESTERN RESERVE UNIVERSITY, OH | First-year cost $1,024,684 | Study section ZCA1 |
| FY2020 | The East Africa Consortium for HPV and Cervical Cancer in Women living with HIV/AIDS1U54CA254518-01 | Brown, Darron RLoehrer, Patrick J.Nakalembe, MiriamOrango, Elkanah Omenge | INDIANA UNIVERSITY INDIANAPOLIS, IN | First-year cost $995,284 | Study section ZCA1 |
| FY2020 | Einstein/Rwanda/DRC Consortium for Research in HIV/HPV/Malignancies1U54CA254568-01 | Adedimeji, AdebolaAnastos, Kathryn M.Mutesa, LeonYotebieng, Marcel | ALBERT EINSTEIN COLLEGE OF MEDICINE, NY | First-year cost $988,290 | Study section ZCA1 |
Patents from its funded projects
5 patents name 1 of the 7 funded projects.
- US 12,755,841 (opens the patent at USPTO, a PDF, in a new tab)MULTI-SITE CROSS-ORGAN CALIBRATED DEEP LEARNING (MUSCID) METHOD AND APPARATUSGranted October 6, 2026 to Case Western Reserve University, Emory University and 2 othersU54CA254566 · CASE WESTERN RESERVE UNIVERSITY, OH
- US 12,530,770 (opens the patent at USPTO, a PDF, in a new tab)DEEP-LEARNING-BASED HEPATIC FAT ASSESSMENTGranted January 20, 2026 to Case Western Reserve University, Emory University and University Hospitals Cleveland Medical CenterU54CA254566 · CASE WESTERN RESERVE UNIVERSITY, OH
- US 12,159,403 (opens the patent at USPTO, a PDF, in a new tab)COMBINATION OF FEATURES FROM BIOPSIES AND SCANS TO PREDICT PROGNOSIS IN SCLCGranted December 3, 2024 to The United States Government as Represented by the Department of Veteran AffairsU54CA254566 · CASE WESTERN RESERVE UNIVERSITY, OH
- US 12,073,560 (opens the patent at USPTO, a PDF, in a new tab)COMPUTATIONAL FEATURES OF TUMOR-INFILTRATING LYMPHOCYTE (TIL) ARCHITECTUREGranted August 27, 2024 to University of Pittsburgh—Of the Commonwealth System of Higher EducationU54CA254566 · CASE WESTERN RESERVE UNIVERSITY, OH
- US 12,037,560 (opens the patent at USPTO, a PDF, in a new tab)COMPUTATIONAL FEATURES OF TUMOR-INFILTRATING LYMPHOCYTE (TIL) ARCHITECTUREGranted July 16, 2024 to BIOCOAT, INCORPORATEDU54CA254566 · CASE WESTERN RESERVE UNIVERSITY, OH
Each number opens the patent at USPTO, beside the project NIH ties it to and that project's institution. NIH ties a patent to a project, not to a year of its funding, and says its list is incomplete. The grant date and the owners are USPTO's: the organizations the patent names as assignees on the day it was granted. Source: United States Patent and Trademark Office, www.uspto.gov, which does not endorse ScienceDex.
Data: Grants.gov's daily extract and NIH's notice pages, award files and patents file, in ScienceGraph release conductgrants-2026-11-22-0.3.11. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.